AU2024000A - Cloning and characterization of two m-rna transcription factors - Google Patents
Cloning and characterization of two m-rna transcription factorsInfo
- Publication number
- AU2024000A AU2024000A AU20240/00A AU2024000A AU2024000A AU 2024000 A AU2024000 A AU 2024000A AU 20240/00 A AU20240/00 A AU 20240/00A AU 2024000 A AU2024000 A AU 2024000A AU 2024000 A AU2024000 A AU 2024000A
- Authority
- AU
- Australia
- Prior art keywords
- cloning
- characterization
- transcription factors
- rna transcription
- rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000040945 Transcription factor Human genes 0.000 title 1
- 108091023040 Transcription factor Proteins 0.000 title 1
- 238000012512 characterization method Methods 0.000 title 1
- 238000010367 cloning Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10824898P | 1998-11-13 | 1998-11-13 | |
| US60108248 | 1998-11-13 | ||
| PCT/US1999/026792 WO2000029578A1 (en) | 1998-11-13 | 1999-11-10 | Cloning and characterization of two m-rna transcription factors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2024000A true AU2024000A (en) | 2000-06-05 |
Family
ID=22321102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU20240/00A Abandoned AU2024000A (en) | 1998-11-13 | 1999-11-10 | Cloning and characterization of two m-rna transcription factors |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2024000A (en) |
| WO (1) | WO2000029578A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2371955A1 (en) * | 2002-09-26 | 2011-10-05 | K.U. Leuven Research & Development | Integrase cofactor |
| GB2393440A (en) * | 2002-09-26 | 2004-03-31 | Leuven K U Res & Dev | Inhibition of retroviral integrase |
| US8168393B2 (en) | 2007-02-16 | 2012-05-01 | The Brigham And Women's Hospital, Inc. | Compositions and methods for diagnosing tumors using LEDGF/p75 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8656098A (en) * | 1997-07-23 | 1999-02-16 | Brigham And Women's Hospital | Lens epithelial cell derived growth factor |
-
1999
- 1999-11-10 WO PCT/US1999/026792 patent/WO2000029578A1/en not_active Ceased
- 1999-11-10 AU AU20240/00A patent/AU2024000A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000029578A9 (en) | 2001-04-05 |
| WO2000029578A1 (en) | 2000-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6529900A (en) | Novel cloning methods and vectors | |
| AU2905997A (en) | Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors | |
| AU4231197A (en) | Hppd gene and inhibitors | |
| AU2409800A (en) | Protective coating and methods for making same | |
| AU4597297A (en) | Trans-sodium crocetinate, methods of making and methods of use thereof | |
| AU7035398A (en) | Compositions and methods for reducing ocular hypertension | |
| AU6774900A (en) | Decorative pop-up stickers and method of making the same | |
| AU4083997A (en) | Gata-6 transcription factor: compositions and methods | |
| AU5668499A (en) | Veneer tape and method of use | |
| AU5800399A (en) | Polish composition and method of use | |
| AU3786299A (en) | Novel serotonin-like 9-substituted hypoxanthine and methods of use | |
| AU2259897A (en) | Methods and compositions for the simultaneous control of rootdiseases | |
| AU3482397A (en) | Method and apparatus for mitigating distortion effects in the determination of signal usability | |
| AU6406000A (en) | Ampholyte polymer composition and method of use | |
| AU5923998A (en) | 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same | |
| AU3494297A (en) | Detection of individual gene transcription and splicing | |
| AU7450900A (en) | Polishing composition and method | |
| AU3118297A (en) | Sok-1 and methods of use | |
| AU4036797A (en) | Cd95 regulatory gene sequences and transcription factors | |
| AU2024000A (en) | Cloning and characterization of two m-rna transcription factors | |
| AU5702698A (en) | Polyprolyl inhibitors of cyclophilin | |
| AU3044199A (en) | Mastic composition and method of preparing same | |
| AU1856297A (en) | Lyst1 and lyst2 gene compositions and methods of use | |
| AU3389197A (en) | $(d)-erythroid kruppel-like factors and methods of use | |
| EP1162608A3 (en) | Optical disk apparatus and method of adjusting the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |